Clinical Trial Update: A Clinical Trial of NS-863 in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD) [Phase 2]

View source ↗

Summary

This document provides an update on a Phase 2 trial of NS-863 in pulmonary hypertension associated with interstitial lung disease (PH-ILD). The study is not yet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Hypertension Associated with Interstitial Lung Disease

Drugs mentioned

• NS-863

Snippet

Sponsor: NS Pharma, Inc. | Conditions: Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD) | Phase 2 | Status: NOT_YET_RECRUITING